Sanofi Repurchases 2.3% of L'Oréal Shares
On February 3, Sanofi announced the acquisition of 2.3% of the shares from long-term shareholder L'Oréal. The transaction is part of Sanofi's share repurchase plan, which is fully in line with Sanofi's capital allocation policy and focuses on creating sustainable value for shareholders.
François Roger, Chief Financial Officer of Sanofi, said, "For decades, L'Oréal has been our trusted shareholder and partner, playing a key role in supporting Sanofi's development and transformation. We are pleased that L'Oréal continues to be one of our largest shareholders. This transaction highlights Sanofi's commitment to sustainable value creation while adhering to our strategic focus and maintaining the strengths of our major partnerships."
The acquisition is an over-the-counter block transaction and is not subject to any specific conditions. L'Oréal will cash out 29.6 million shares at a price of 101.50 euros per share, netting 3 billion euros. After the transaction is completed, L'Oréal will hold 7.2% of Sanofi's shares.
Sanofi shares have risen about 20% in the past 12 months, and L'Oréal has used the gains to revamp its balance sheet following a series of acquisitions.
2026-08-07
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
L'Oréal to Invest $80 Million in Mexico Factory Expansion
-
L'Oréal's Performance in the First Half of 2025 Was Solid: Growth Across All Business Lines and Continued Improvement in Profit Margins
-
L'Oréal Acquires Professional Hair Care Brand Color Wow
-
L'Oréal May Soon Acquire Medik8 for 1 Billion Euros
-
L'Oréal UK sales hit £1.5 billion
-
L'Oréal's SalonCentric Acquires Concept JP
-
L'Oréal's Quarterly Sales Growth Hit a New Low Since the Epidemic Due to the Weak Chinese Market
-
L'Oréal acquires Korean skincare brand Dr.G from Swiss conglomerate Migros
-
L'Oréal sells Decléor and Saint-Gervais Mont Blanc to Cospal to streamline portfolio
-
The largest investment in China! Sanofi to invest 1 billion euros to build a new insulin production base in Beijing
Recommend Reading
-
BASF, Sinopec Forge Green Alliance to Power Nanjing Site with Certified Bio-Methane
-
Cabot Corporation to acquire carbon black facility from Bridgestone in Mexico
-
“The Agency Revolution”: BASF Breaks Into Dongfeng Liuzhou’s Supply Chain
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
Breakup! Vland Biotech and Evonik Part Ways as GHS Joint Venture Falls Short of Expectations
-
This week, the caustic soda price remains stable (7.28-7.31) in China
-
Negative Factors Remain, Hydrogen Peroxide Market Prices Decline
-
This week, the market price of propylene oxide in China has risen (12.1-12.3)
-
Cost Support July Shandong Asphalt Market Rises
-
Weak Demand and Strong Supply in the Off-Season, ABS Prices Decline in July